Photocure ASA: Invitation To Presentation Of Second Quarter ...| MENAFN.COM

Friday, 19 August 2022 05:16 GMT

Photocure ASA: Invitation To Presentation Of Second Quarter And First Half Year 2022 Financial Results'

(MENAFN- PR Newswire)

OSLO, Norway, Aug. 4, 2022 /PRNewswire/ -- Photocure ASA (Photocure, PHO: OSE) will announce the second quarter and first half year 2022 financial results on Wednesday 10 August 2022 at 08:00 CEST and invites investors, analysts and the media to a presentation at Hotel Continental, Oslo, Norway at 14:00 CEST the same day.

The investor presentation will also be streamed live and be hosted by Daniel Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English and questions can be submitted throughout the event.

The presentation is scheduled to conclude at 14:45 CEST.

The quarterly report and presentation will be published at 08:00 CEST and will be publicly available at . The streaming event is available through

For further information, please contact:

Photocure Erik DahlCFOTel: +47 45055000Email: [email protected]

Media and IR enquiries:Geir BjørloCorporate Communications (Norway) Tel: +47 91540000Email: [email protected]

About Photocure Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at , ,

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

This information was brought to you by Cision

The following files are available for download:


SOURCE Photocure


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.